Theriva Biologics, Inc. (TOVX) Misses Q3 EPS by 652c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
Tweet
Share
E-mailGet Alerts TOVX Hot Sheet
Join SI Premium – FREE
Theriva Biologics, Inc. (NYSE: TOVX) reported Q3 EPS of ($6.81), $6.52 worse than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Grainger (GWW) Tops Q3 EPS by 87c ; Offers Guidance
- Arista Networks (ANET) PT Raised to $240 at Truist Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
